David da Silva Te
Overview
Explore the profile of David da Silva Te including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engell-Sorensen T, Rieckmann A, Medina C, da Silva Te D, Rodrigues A, Fisker A, et al.
Infection
. 2021 Feb;
49(4):631-643.
PMID: 33528814
Purpose: To estimate the life expectancy (LE) of HIV-infected patients in the West African country Guinea-Bissau and compare it with the background population. Methods: Using data from the largest HIV...
2.
Rasmussen D, Vieira N, Honge B, da Silva Te D, Jespersen S, Bjerregaard-Andersen M, et al.
Sci Rep
. 2020 Jul;
10(1):12174.
PMID: 32699381
The human immunodeficiency virus (HIV) remains a leading cause of maternal morbidity and mortality in Sub-Saharan Africa. Prevention of mother-to-child transmission (PMTCT) has proven an effective strategy to end paediatric...
3.
Kjerulff B, Petersen M, Rodrigues C, da Silva Te D, Christiansen M, Erikstrup C, et al.
Immunobiology
. 2019 Dec;
225(2):151878.
PMID: 31810824
Human T-lymphotropic virus (HTLV) affects the human immune system in many ways, most notably by inducing proliferation of infected CD4 + T cells, but several other cell types are also...
4.
Honge B, Jespersen S, Medina C, da Silva Te D, da Silva Z, Christiansen M, et al.
Trans R Soc Trop Med Hyg
. 2019 Jun;
113(9):555-559.
PMID: 31162598
Background: Discrimination among HIV types is important because HIV-2 is naturally resistant to some of the first-line drugs used in the treatment of HIV-1. We evaluated three assays for HIV-type...
5.
Rasmussen D, Unger H, Bjerregaard-Andersen M, da Silva Te D, Vieira N, Oliveira I, et al.
PLoS One
. 2019 Feb;
14(2):e0212240.
PMID: 30730991
[This corrects the article DOI: 10.1371/journal.pone.0199819.].
6.
Rasmussen D, Unger H, Bjerregaard-Andersen M, da Silva Te D, Vieira N, Oliveira I, et al.
PLoS One
. 2018 Aug;
13(8):e0199819.
PMID: 30067793
Background: The World Health Organization recommends HIV testing is included in routine screening tests for all pregnant women in order to prevent mother-to-child-transmission of HIV and reduce maternal morbidity and...
7.
Jespersen S, Honge B, Krarup H, Medstrand P, Sorensen A, Medina C, et al.
J Acquir Immune Defic Syndr
. 2018 Jul;
79(3):386-393.
PMID: 30044302
Background: Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are recommended as part of first-line treatment for HIV-1 in Africa. However, NNRTI-based regimens are more prone to resistance development than protease inhibitors (PIs)...
8.
Andersen M, Honge B, Jespersen S, Medina C, da Silva Te D, Laursen A, et al.
J Infect Dis
. 2018 May;
218(8):1291-1295.
PMID: 29800140
Macrophages play important roles during human immunodeficiency virus (HIV) infection, reflected by changes in macrophage-activation biomarker soluble CD163 (sCD163). Here, we present data on the novel macrophage-activation biomarker soluble mannose...
9.
Thomsen D, Hviid C, Honge B, Medina C, da Silva Te D, Correira F, et al.
Pan Afr Med J
. 2018 Apr;
29:18.
PMID: 29662603
Cryptococcal antigenemia may precede development of cryptococcal meningitis and death among patients with advanced HIV infection. Among 200 retrospectively and randomly selected ART-naïve patients with CD4 counts < 100 cells/μl...
10.
Thomsen D, Erikstrup C, Jespersen S, Medina C, da Silva Te D, Correira F, et al.
AIDS
. 2018 Jan;
32(6):721-728.
PMID: 29369163
Objectives: HIV-2 is endemic in West Africa and is characterized by lower transmissibility because of lower viral load, and HIV-2-infected persons usually have a slower progression to AIDS. The mechanisms...